Ahmed Nawaz Khan

  • M.Pharm, PGDPRA, PhD.
    Assistant Professor
    Phone: +91-9736557866
    Email: ahmednawaz@theglocaluniversity.in



    EDUCATION

    Qualification

    Year

    University

    Ph. D

    2016

    Jaypee University of Information Technology, Waknaghat, Distt. Solan, Himachal Pradesh, India

    PGD Diploma Pharmaceutical Regulatory Affairs (Distance Learning)

    2009

    Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

    M.Pharm Pharmaceutical Chemistry

    2009

    Babu Banarsi Das National Institute of Technology and Management (Under UPTU), Faizabad Road, Lucknow, India

    B.Pharm

    2007

    Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

    RESEARCH INTEREST

    1. Counterfeit and Substandard Medicine

    2. Patient’s Treatment Non Adherence

    3. Medicine Irrational Use

    4. Near Infrared and Chemometric Procedures

    5. Pharmaceutical Regulatory Affairs & Challenges

    6. Public Health

    7. Life Science Entrepreneurship

    PROFESSIONAL EXPERIENCE

    • 05 August 2017 to Present, Assistant Professor, School of Pharmacy, Glocal University, Mirzapur Pole, Distt. Saharanpur-2471001, U.P., India
    • 01 July 2010 to 04 August 2017, Assistant Professor, Dept. of Pharmacy, Jaypee University of Information Technology, Waknaghat, Distt. Solan-173234, H.P., India
    • January 2010- May 2010, Junior Research Fellow, Talwar Research Foundation, Neb Velley, New Delhi, India
    • November 2008 to July 2009, Research Analyst Trainee, Jubilant Organosys, Noida, U.P., India

    SELECTED RESEARCH PUBLICATIONS DETAILS

    SELECTED RESEARCH PUBLICATIONS DETAILS

    • “Current scenario of spurious and substandard medicines in India: A systematic review,” Indian Journal of Pharmaceutical Sciences, vol. 77, no. 1,
       pp. 2–7, 2015.
    • “Medicine prescribing preference and patient adherence: perspectives of Indian medical practitioners,” Journal of Young Pharmacist, vol. 7, no. 4
       (Supple), pp. 446-454, 2015. DOI: 10.5530/jyp.2015.4s.6
    • “Pilot study of quality of diclofenac generic products using validated in-house method: Indian drug regulatory concern,” Journal of Applied Pharmaceutical Science, vol. 5 (12), pp. 147-153, Dec-2015.
    • “Quality and affordability of amoxicillin generic products: a patient concern,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8,
       Issue 1, pp. 386-390 Jan-2016. 
    • “Diffuse reflectance near infrared–chemometric method development and validation of amoxicillin capsule formulations,” Journal of Pharmacy and Bioallied Sciences, vol. 8, no. 2,
      pp. 152-160, April 2016. 
    • "Multivariate calibration and validation for identification and quantification of diclofenac in tablet using near infrared spectroscopy,” 2016 (Under Communication)
    • “Patients non adherence indicators: A cross sectional study in India,, 2016. (Under Communication)

    Participations

    • UGC Networking Resource Centre for Training in Pharmaceutical Sciences, UIPS, Punjab University, “ Current Trends In Pharmaceutical Analysis & Medicinal Chemistry”, January 24-29, 2011
    • Faculty Development Programme, “Outcome Based Education in Biotechnology and Bioinformatics”, Jaypee University of Information Technology, 24-30 Dec. 2015
    • Innovation and Intellectual Property Rights Workshop, Jaypee University of Information Technology, 9 Dec. 2016

    MEDIA COVERAGE on MY RESEARCH

    1 In 7 Indian Drugs Revealed As Substandard , Charu Bahri, February 15, 2016
    IndiaSpend Newsletter, abplive, rediff and many more…
    http://www.indiaspend.com/cover-story/1-in-7-indian-drugs-revealed-as-substandard-97614
    http://www.abplive.in/india-news/1-in-7-indian-drugs-revealed-as-sub-standard-291071
    http://www.rediff.com/money/special/special-beware-1-in-7-indian-medicines-revealed-assubstandard/20160216.htm

    Drug Controller begins review of alarming findings on substandard drugs from a new pilot study By E Kumar Sharma, February 18, 2016
    Business Today
    http://www.businesstoday.in/sectors/pharma/drug-controller-findings-on-substandard-drugsnew-pilot-study/story/229316.html

    Low-quality drugs in India raise concerns, By K. V. Venkatasubramanian, February 29, 2016
    Special to C&EN, American Chemical Society (ACS) Magazine
    http://cen.acs.org/articles/94/i9/Low-quality-drugs-India-raise.html?type=paidArticleContent

    Many Indian Drugs Sub-standard, Reveals New Study, By Charu Bahri February 16, 2016
    IndiaWest
    http://bloximages.chicago2.vip.townnews.com/indiawest.com/content/tncms/assets/v3/eedition/b/ef/bef7650f-0677-5c88-ab33-264d06c1afda/56c51152a82fc.pdf

    High percentage of drugs in the Indian market is substandard, Written by Thomas Lim
    Meghalaya Times
    http://meghalayatimes.info/index.php/editorial/33369-high-percentage-of-drugs-in-theindian-market-is-substandard